Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
First-line chemotherapy standard of care for Hodgkin Lymphoma.
Intermediate and high-risk pediatric and adolescent Hodgkin Lymphoma.
High-risk pediatric Hodgkin Lymphoma (Children's Oncology Group protocol).
Adjuvant and neoadjuvant treatment of early-stage and locally advanced Breast Cancer.
Adjuvant treatment of node-positive or high-risk node-negative Breast Cancer.
Induction therapy for Acute Myeloid Leukemia (AML) in pediatric and adult patients.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
HR-positive, HER2-negative advanced, metastatic, or high-risk early Breast Cancer.
Metastatic Castration-Resistant Prostate Cancer (mCRPC) and High-Risk Castration-Sensitive Prostate Cancer in combination with prednisone.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
